These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4274689)

  • 21. [Experimental data on the efficacy of the kallikrein-trypsin inactivator (Trasylol)].
    GUELZOW M; TRETTIN HJ; DIWOK K
    Klin Wochenschr; 1961 Jun; 39():597-8. PubMed ID: 13709414
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical use of natural kallikrein-protease inhibitors].
    Sudneva LI
    Klin Med (Mosk); 1981 Jun; 59(6):8-12. PubMed ID: 6169874
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the use of the kallikrein-trypsin inactivator "Trasylol" in acute pancreatitis and similar disease states].
    KYRLE P
    Wien Klin Wochenschr; 1962 Jan; 74():5-9. PubMed ID: 14461137
    [No Abstract]   [Full Text] [Related]  

  • 24. Some observations on proteinase inhibitor therapy for decompression sickness in the rat.
    Frattali V; Quesada M; Robertson R; Shackelford A
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1033-42. PubMed ID: 4543397
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibitory effects of -amino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.
    Muramatu M; Fujii S
    Biochim Biophys Acta; 1971 Jul; 242(1):203-8. PubMed ID: 4256355
    [No Abstract]   [Full Text] [Related]  

  • 26. Purification of a new plasma inhibitor of kallikrein.
    Sumi H; Fujii S
    J Biochem; 1974 Mar; 75(3):541-51. PubMed ID: 4276127
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of 2 -macroglobulin in bovine plasma. 3. Its actions on bovine plasma kallikrein, plasmin and thrombin.
    Sugihara H; Nagasawa S; Suzuki T
    J Biochem; 1971 Oct; 70(4):649-58. PubMed ID: 4257424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characterization of porcine and human serum kallikrein using inhibition through protein-proteinase inhibitors].
    Wunderer G; Kummer K; Fritz H
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1646-50. PubMed ID: 4539798
    [No Abstract]   [Full Text] [Related]  

  • 29. [State of the kallikrein-kinin system and anti-enzyme therapy in acute peritonitis in children].
    Matskevich BI
    Vestn Khir Im I I Grek; 1982 Aug; 129(8):90-4. PubMed ID: 6182678
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.
    Tamura Y; Hirado M; Okamura K; Minato Y; Fujii S
    Biochim Biophys Acta; 1977 Oct; 484(2):417-22. PubMed ID: 143965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in the therapy of inflammatory diseases of the pancreas. A report on 1 year of therapy and prophylaxis with the kallikrein- and trypsin inactivator trasylol (Bayer)].
    ASANG E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1960; 293():645-70. PubMed ID: 13794633
    [No Abstract]   [Full Text] [Related]  

  • 32. Kallikrein inhibitors.
    Fritz H; Fink E; Truscheit E
    Fed Proc; 1979 Dec; 38(13):2753-9. PubMed ID: 315885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents.
    Flight S; Johnson L; Trabi M; Gaffney P; Lavin M; de Jersey J; Masci P
    Pathophysiol Haemost Thromb; 2005; 34(4-5):188-93. PubMed ID: 16707925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.
    Dubber AH; McNicol GP; Uttley D; Douglas AS
    Br J Haematol; 1968 Jan; 14(1):31-49. PubMed ID: 4229180
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitory effects of aprotinin on kallikrein and kininases in dog's blood.
    Pojda SM; Vane JR
    Br J Pharmacol; 1971 Aug; 42(4):558-68. PubMed ID: 5315684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Occurrence and properties of a proteinase inhibitor in human nasal secretion].
    Hochstrasser K; Haendle H; Reichert R; Werle E
    Hoppe Seylers Z Physiol Chem; 1971 Jul; 352(7):954-8. PubMed ID: 4254771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Trasylol treatment in inflammatory pancreatic diseases].
    BALG KH; LIESER H
    Med Welt; 1961 Oct; 42():2175-7. PubMed ID: 13864369
    [No Abstract]   [Full Text] [Related]  

  • 39. [RESEARCH ON THE ACTION OF A KALLIKREIN AND TRYPSIN INHIBITOR ON THE COURSE OF EXPERIMENTAL HEPATITIS OF THE MOUSE DUE TO MHV-3].
    PIAZZA M; PICCININO F; DISTASIO G
    Riv Ist Sieroter Ital; 1964; 39():389-93. PubMed ID: 14219326
    [No Abstract]   [Full Text] [Related]  

  • 40. Trypsin-kallikrein isoinhibitor K (type Kunitz) from snails (Helix pomatia). Purification and characterization.
    Dietl T; Tschesche H
    Eur J Biochem; 1975 Oct; 58(2):453-60. PubMed ID: 1081050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.